In 2009, a study performed to identify single nucleotide polymorphisms (SNPs) that determine the effect of IFN-based therapy in chronic hepatitis C patients revealed the importance of a SNP near the IL28B gene [70]. This evidence concerns the gene IFNA1 and chronic hepatitis C virus infection.